Nurse Practitioner · North Wilkesboro, NC
NPI
1952442527
Since 2007
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
112 Boone Trl
North Wilkesboro, NC, 28659
Phone (336) 667-8241
Groups this clinician bills Medicare through
Medicare paid, 2024
$43K
1,170 services
Medicare patients, 2024
116
Average age 70
Drug cost, 2024
$934K
10,932 prescriptions
Company payments, 2025
$973
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pamela S Sloop was code 99214 (office e&m - established), 464 times for 111 patients. In total Pamela S Sloop billed 1,170 services in 35 codes, and Medicare paid $43K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 464 | 111 | $68.88 | $32K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 121 | 15 | $0.08 | $9.7 |
| 99213 Office E&M - Established | Office | 119 | 54 | $48.52 | $5,774 |
| 81001 Clinical Chemistry | Office | 43 | 21 | $3.11 | $134 |
| 81015 Clinical Chemistry | Office | 31 | 21 | $2.99 | $92.69 |
| 87804 Immunoassay | Office | 20 | 15 | $16.22 | $324 |
| 87426 Immunoassay | Office | 19 | 14 | $34.62 | $658 |
| 99215 Office E&M - Established | Office | 19 | 17 | $90.52 | $1,720 |
| 82274 Immunoassay | Office | 13 | 13 | $15.60 | $203 |
By year: 2022 $36K for 978 services; 2023 $36K for 1,082 services; 2024 $43K for 1,170 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 43 | 21 | $3.11 | $134 |
| 81015 Clinical Chemistry | 31 | 21 | $2.99 | $92.69 |
| 87804 Immunoassay | 20 | 15 | $16.22 | $324 |
| 87426 Immunoassay | 19 | 14 | $34.62 | $658 |
| 82274 Immunoassay | 13 | 13 | $15.60 | $203 |
Medicare prescription drug claims, 2024
In 2024, the drug Pamela S Sloop prescribed most often to Medicare patients was Levothyroxine Sodium, with 645 prescriptions and refills. In total Pamela S Sloop wrote 10,932 Medicare prescriptions that cost $934K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 645 | 1,530 | 158 | $6,357 |
| Alprazolam Generic | 381 | 381 | 50 | $1,396 |
| Omeprazole Generic | 246 | 619 | 70 | $5,517 |
| Cyclobenzaprine Hcl Generic | 235 | 280 | 67 | $4,388 |
| Atorvastatin Calcium Generic | 224 | 516 | 57 | $1,936 |
| Lisinopril Generic | 211 | 552 | 62 | $1,064 |
| Potassium Chloride Generic | 210 | 435 | 60 | $3,011 |
| Hydrochlorothiazide Generic | 209 | 565 | 66 | $910 |
| Azithromycin Generic | 206 | 206 | 109 | $530 |
| Lorazepam Generic | 202 | 210 | 42 | $1,121 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 202 | 243 | 48 | $4,163 |
| Gabapentin Generic | 194 | 271 | 39 | $3,644 |
| Zolpidem Tartrate Generic | 189 | 216 | 30 | $1,729 |
| Nystatin Generic | 178 | 184 | 85 | $2,035 |
| Fluconazole Generic | 173 | 175 | 78 | $1,155 |
Brand drugs: 1,631 claims; generic drugs: 9,276 claims; opioid claims: 118.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pamela S Sloop $973 ($973 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $288.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 28 | $288 |
| Pfizer Inc. PFE | 6 | $140 |
| Ardelyx, Inc. ARDX | 5 | $128 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $84.22 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $70.43 |
| Axsome Therapeutics, Inc. AXSM | 3 | $57.81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $38.47 |
| Corcept Therapeutics CORT | 2 | $33.85 |
| Novo Nordisk Inc NVO | 1 | $22.05 |
| Astellas Pharma US Inc 4503.T | 1 | $21.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.